{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T17:13:59Z","timestamp":1779124439684,"version":"3.51.4"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Precise temporal control of protein abundance is essential for dissecting dynamic cellular processes. While degron-based systems enable rapid protein depletion in eukaryotic cells, comparable tools are lacking for bacterial effectors delivered into host cells during infection. Here, we establish AIDE (Auxin-Inducible Degradation of Effectors), a host-directed degradation platform that harnesses the ubiquitin-proteasome system to selectively eliminate secreted bacterial proteins, including membrane-integrated effectors. By integrating a minimal auxin-inducible degron (AID) tag into effector genes, AIDE enables rapid, reversible, and spatially confined degradation while preserving native expression and secretion. We apply AIDE to\n                    <jats:italic>Chlamydia trachomatis<\/jats:italic>\n                    and show, that the membrane-integrated deubiquitinase Cdu1 suppresses autophagy early and later promotes developmental transitions, whereas the integral membrane fusogen IncA remains continuously required to maintain homotypic inclusion fusion. This AIDE platform provides minute-scale, spatiotemporal control over bacterial effector activity and offers a broadly applicable framework for dissecting virulence mechanisms and host-pathogen interactions across diverse secretion-dependent pathogens.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-73213-x","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:54:26Z","timestamp":1779116066000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Minute-scale control of ubiquitin-mediated degradation reveals dynamics of bacterial secreted effector-functions"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6470-4272","authenticated-orcid":false,"given":"Haolin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongxia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9064-0356","authenticated-orcid":false,"given":"Bikash","family":"Adhikari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nevenka","family":"Dudvarski-Stankovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5299-6335","authenticated-orcid":false,"given":"Elmar","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4740-6991","authenticated-orcid":false,"given":"Thomas","family":"Rudel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"73213_CR1","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/S0140-6736(22)02185-7","volume":"400","author":"KS Ikuta","year":"2022","unstructured":"Ikuta, K. S. et al. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 400, 2221\u20132248 (2022).","journal-title":"Lancet"},{"key":"73213_CR2","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.tibs.2022.04.013","volume":"47","author":"J Jenkins","year":"2022","unstructured":"Jenkins, J., Worrall, L. J. & Strynadka, N. C. J. Recent structural advances towards understanding of the bacterial type III secretion injectisome. Trends Biochem. Sci. 47, 795\u2013809 (2022).","journal-title":"Trends Biochem. Sci."},{"key":"73213_CR3","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.cell.2018.01.034","volume":"172","author":"JE Gal\u00e1n","year":"2018","unstructured":"Gal\u00e1n, J. E. & Waksman, G. Protein-injection machines in bacteria. Cell 172, 1306\u20131318 (2018).","journal-title":"Cell"},{"key":"73213_CR4","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.tim.2013.06.008","volume":"21","author":"B Raymond","year":"2013","unstructured":"Raymond, B. et al. Subversion of trafficking, apoptosis, and innate immunity by type III secretion system effectors. Trends Microbiol. 21, 430\u2013441 (2013).","journal-title":"Trends Microbiol."},{"key":"73213_CR5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.tim.2018.01.010","volume":"26","author":"L Pinaud","year":"2018","unstructured":"Pinaud, L., Sansonetti, P. J. & Phalipon, A. Host cell targeting by enteropathogenic bacteria T3SS effectors. Trends Microbiol. 26, 266\u2013283 (2018).","journal-title":"Trends Microbiol."},{"key":"73213_CR6","doi-asserted-by":"crossref","unstructured":"Wagner S., et al. Bacterial type III secretion systems: a complex device for the delivery of bacterial effector proteins into eukaryotic host cells. FEMS Microbiol. Lett. 365, 201 (2018).","DOI":"10.1093\/femsle\/fny201"},{"key":"73213_CR7","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1146\/annurev-micro-032521-025503","volume":"77","author":"LJ Worrall","year":"2023","unstructured":"Worrall, L. J., Majewski, D. D. & Strynadka, N. C. J. Structural insights into type III secretion systems of the bacterial flagellum and injectisome. Annu. Rev. Microbiol. 77, 669\u2013698 (2023).","journal-title":"Annu. Rev. Microbiol."},{"key":"73213_CR8","doi-asserted-by":"publisher","first-page":"R784","DOI":"10.1016\/j.cub.2014.07.016","volume":"24","author":"A Puhar","year":"2014","unstructured":"Puhar, A. & Sansonetti, P. J. Type III secretion system. Curr. Biol. 24, R784\u2013R791 (2014).","journal-title":"Curr. Biol."},{"key":"73213_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1113442","volume":"14","author":"J De Ryck","year":"2023","unstructured":"De Ryck, J., Van Damme, P. & Goormachtig, S. From prediction to function: current practices and challenges towards the functional characterization of type III effectors. Front. Microbiol. 14, 1113442 (2023).","journal-title":"Front. Microbiol."},{"key":"73213_CR10","doi-asserted-by":"crossref","unstructured":"Denzer L., Schroten H., Schwerk C. From gene to protein-how bacterial virulence factors manipulate host gene expression during infection. Int. J. Mol. Sci. 21, 3730 (2020).","DOI":"10.3390\/ijms21103730"},{"key":"73213_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1185571","volume":"13","author":"CM Riffaud","year":"2023","unstructured":"Riffaud, C. M., Rucks, E. A. & Ouellette, S. P. Persistence of obligate intracellular pathogens: alternative strategies to overcome host-specific stresses. Front. Cell Infect. Microbiol. 13, 1185571 (2023).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"73213_CR12","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/s41573-019-0047-y","volume":"18","author":"M Schapira","year":"2019","unstructured":"Schapira, M., Calabrese, M. F., Bullock, A. N. & Crews, C. M. Targeted protein degradation: expanding the toolbox. Nat. Rev. Drug Discov. 18, 949\u2013963 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"73213_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","volume":"21","author":"M B\u00e9k\u00e9s","year":"2022","unstructured":"B\u00e9k\u00e9s, M., Langley, D. R. & Crews, C. M. PROTAC targeted protein degraders: the past is prologue. Nat. Rev. Drug Discov. 21, 181\u2013200 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"73213_CR14","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1002\/anie.201507978","volume":"55","author":"M Toure","year":"2016","unstructured":"Toure, M. & Crews, C. M. Small-molecule PROTACS: new approaches to protein degradation. Angew. Chem. Int Ed. Engl. 55, 1966\u20131973 (2016).","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"73213_CR15","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41580-024-00729-9","volume":"25","author":"JM Tsai","year":"2024","unstructured":"Tsai, J. M., Nowak, R. P., Ebert, B. L. & Fischer, E. S. Targeted protein degradation: from mechanisms to clinic. Nat. Rev. Mol. Cell Biol. 25, 740\u2013757 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"73213_CR16","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.cell.2017.10.033","volume":"171","author":"D Clift","year":"2017","unstructured":"Clift, D. et al. A method for the acute and rapid degradation of endogenous proteins. Cell 171, 1692\u20131706.e1618 (2017).","journal-title":"Cell"},{"key":"73213_CR17","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nmeth.1401","volume":"6","author":"K Nishimura","year":"2009","unstructured":"Nishimura, K., Fukagawa, T., Takisawa, H., Kakimoto, T. & Kanemaki, M. An auxin-based degron system for the rapid depletion of proteins in nonplant cells. Nat. Methods 6, 917\u2013922 (2009).","journal-title":"Nat. Methods"},{"key":"73213_CR18","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1021\/acschembio.5b00442","volume":"10","author":"DL Buckley","year":"2015","unstructured":"Buckley, D. L. et al. HaloPROTACS: use of small molecule PROTACs to induce degradation of halotag fusion proteins. ACS Chem. Biol. 10, 1831\u20131837 (2015).","journal-title":"ACS Chem. Biol."},{"key":"73213_CR19","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41589-018-0021-8","volume":"14","author":"B Nabet","year":"2018","unstructured":"Nabet, B. et al. The dTAG system for immediate and target-specific protein degradation. Nat. Chem. Biol. 14, 431\u2013441 (2018).","journal-title":"Nat. Chem. Biol."},{"key":"73213_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19532-z","volume":"11","author":"A Yesbolatova","year":"2020","unstructured":"Yesbolatova, A. et al. The auxin-inducible degron 2 technology provides sharp degradation control in yeast, mammalian cells, and mice. Nat. Commun. 11, 5701 (2020).","journal-title":"Nat. Commun."},{"key":"73213_CR21","doi-asserted-by":"publisher","DOI":"10.1128\/jb.00361-24","volume":"207","author":"EP Smith","year":"2025","unstructured":"Smith, E. P. & Valdivia, R. H. Chlamydia trachomatis: a model for intracellular bacterial parasitism. J. Bacteriol. 207, e0036124 (2025).","journal-title":"J. Bacteriol."},{"key":"73213_CR22","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41579-023-00860-y","volume":"21","author":"K Stelzner","year":"2023","unstructured":"Stelzner, K., Vollmuth, N. & Rudel, T. Intracellular lifestyle of Chlamydia trachomatis and host-pathogen interactions. Nat. Rev. Microbiol. 21, 448\u2013462 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"73213_CR23","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrmicro.2016.30","volume":"14","author":"C Elwell","year":"2016","unstructured":"Elwell, C., Mirrashidi, K. & Engel, J. Chlamydia cell biology and pathogenesis. Nat. Rev. Microbiol. 14, 385\u2013400 (2016).","journal-title":"Nat. Rev. Microbiol."},{"key":"73213_CR24","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1042\/BST20240800","volume":"0","author":"TJ Zimmerman","year":"2025","unstructured":"Zimmerman, T. J. & Carabeo, R. A. Chlamydia trachomatis invasion: a duet of effectors. Biochem. Soc. Trans. 0, 363\u2013370 (2025).","journal-title":"Biochem. Soc. Trans."},{"key":"73213_CR25","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02614-22","volume":"11","author":"A Haines","year":"2023","unstructured":"Haines, A., Wesolowski, J. & Paumet, F. Chlamydia trachomatis subverts alpha-actinins to stabilize its inclusion. Microbiol. Spectr. 11, e0261422 (2023).","journal-title":"Microbiol. Spectr."},{"key":"73213_CR26","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.celrep.2017.04.058","volume":"19","author":"MM Weber","year":"2017","unstructured":"Weber, M. M. et al. Absence of specific chlamydia trachomatis inclusion membrane proteins triggers premature inclusion membrane lysis and host cell death. Cell Rep. 19, 1406\u20131417 (2017).","journal-title":"Cell Rep."},{"key":"73213_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.chom.2016.12.002","volume":"21","author":"BS Sixt","year":"2017","unstructured":"Sixt, B. S. et al. The chlamydia trachomatis inclusion membrane protein CpoS counteracts STING-mediated cellular surveillance and suicide programs. Cell Host Microbe 21, 113\u2013121 (2017).","journal-title":"Cell Host Microbe"},{"key":"73213_CR28","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.chom.2022.08.008","volume":"30","author":"SC Walsh","year":"2022","unstructured":"Walsh, S. C. et al. The bacterial effector GarD shields Chlamydia trachomatis inclusions from RNF213-mediated ubiquitylation and destruction. Cell Host Microbe 30, 1671\u20131684 (2022).","journal-title":"Cell Host Microbe"},{"key":"73213_CR29","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00491-22","volume":"91","author":"PN McCaslin","year":"2023","unstructured":"McCaslin, P. N. et al. Identification and preliminary characterization of novel type III secreted effector proteins in chlamydia trachomatis. Infect. Immun. 91, e0049122 (2023).","journal-title":"Infect. Immun."},{"key":"73213_CR30","doi-asserted-by":"publisher","first-page":"414","DOI":"10.15698\/mic2019.09.691","volume":"6","author":"JN Bugalh\u00e3o","year":"2019","unstructured":"Bugalh\u00e3o, J. N. & Mota, L. J. The multiple functions of the numerous Chlamydia trachomatis secreted proteins: the tip of the iceberg. Micro. Cell 6, 414\u2013449 (2019).","journal-title":"Micro. Cell"},{"key":"73213_CR31","doi-asserted-by":"crossref","unstructured":"Ehses J., et al. Development of an sRNA-mediated conditional knockdown system for Chlamydia trachomatis. mBio 16, 2545 (2024).","DOI":"10.1128\/mbio.02545-24"},{"key":"73213_CR32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fcimb.2018.00059","volume":"8","author":"SP Ouellette","year":"2018","unstructured":"Ouellette, S. P. Feasibility of a conditional knockout system for chlamydia based on CRISPR interference. Front. Cell Infect. Microbiol. 8, 59 (2018).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"73213_CR33","doi-asserted-by":"crossref","unstructured":"Ouellette Scot P., Blay Emmanuel A., Hatch Nathan D., Fisher-Marvin Laura A. CRISPR interference to inducibly repress gene expression in chlamydia trachomatis. Infect. Immunity 89, e00108-21 (2021).","DOI":"10.1128\/IAI.00108-21"},{"key":"73213_CR34","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1038\/nprot.2013.132","volume":"8","author":"MH Larson","year":"2013","unstructured":"Larson, M. H. et al. CRISPR interference (CRISPRi) for sequence-specific control of gene expression. Nat. Protoc. 8, 2180\u20132196 (2013).","journal-title":"Nat. Protoc."},{"key":"73213_CR35","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature10098","volume":"473","author":"B Schwanh\u00e4usser","year":"2011","unstructured":"Schwanh\u00e4usser, B. et al. Global quantification of mammalian gene expression control. Nature 473, 337\u2013342 (2011).","journal-title":"Nature"},{"key":"73213_CR36","doi-asserted-by":"crossref","unstructured":"Fischer A., et al. Chlamydia trachomatis-containing vacuole serves as deubiquitination platform to stabilize MCL-1 and to interfere with host defense. Elife 6, e21465 (2017).","DOI":"10.7554\/eLife.21465"},{"key":"73213_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.13136","volume":"22","author":"D Auer","year":"2020","unstructured":"Auer, D., H\u00fcgelsch\u00e4ffer, S. D., Fischer, A. B. & Rudel, T. The chlamydial deubiquitinase Cdu1 supports recruitment of Golgi vesicles to the inclusion. Cell Microbiol. 22, e13136 (2020).","journal-title":"Cell Microbiol."},{"key":"73213_CR38","doi-asserted-by":"crossref","unstructured":"Bastidas R. J., et al. The acetylase activity of Cdu1 regulates bacterial exit from infected cells by protecting Chlamydia effectors from degradation. Elife 12, RP87386 (2024).","DOI":"10.7554\/eLife.87386.3"},{"key":"73213_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10806-9","volume":"10","author":"G Cingolani","year":"2019","unstructured":"Cingolani, G. et al. Structural basis for the homotypic fusion of chlamydial inclusions by the SNARE-like protein IncA. Nat. Commun. 10, 2747 (2019).","journal-title":"Nat. Commun."},{"key":"73213_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53443-7","volume":"15","author":"C Linton","year":"2024","unstructured":"Linton, C. et al. Specialized contact sites regulate the fusion of chlamydial inclusion membranes. Nat. Commun. 15, 9250 (2024).","journal-title":"Nat. Commun."},{"key":"73213_CR41","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00453-22","volume":"90","author":"KA Fields","year":"2022","unstructured":"Fields, K. A., Bodero, M. D., Scanlon, K. R., Jewett, T. J. & Wolf, K. A minimal replicon enables efficacious, species-specific gene deletion in chlamydia and extension of gene knockout studies to the animal model of infection using chlamydia muridarum. Infect. Immun. 90, e0045322 (2022).","journal-title":"Infect. Immun."},{"key":"73213_CR42","doi-asserted-by":"publisher","first-page":"5822","DOI":"10.1039\/C8SC02353K","volume":"9","author":"W Zhao","year":"2018","unstructured":"Zhao, W. et al. A chemically induced proximity system engineered from the plant auxin signaling pathway. Chem. Sci. 9, 5822\u20135827 (2018).","journal-title":"Chem. Sci."},{"key":"73213_CR43","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3389\/fcimb.2019.00276","volume":"9","author":"TC Kunz","year":"2019","unstructured":"Kunz, T. C., G\u00f6tz, R., Sauer, M. & Rudel, T. Detection of chlamydia developmental forms and secreted effectors by expansion microscopy. Front. Cell Infect. Microbiol. 9, 276 (2019).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"73213_CR44","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.molcel.2017.10.028","volume":"69","author":"J van den Boom","year":"2018","unstructured":"van den Boom, J. & Meyer, H. VCP\/p97-mediated unfolding as a principle in protein homeostasis and signaling. Mol. Cell 69, 182\u2013194 (2018).","journal-title":"Mol. Cell"},{"key":"73213_CR45","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.3389\/fmicb.2019.02350","volume":"10","author":"M Yang","year":"2019","unstructured":"Yang, M., Rajeeve, K., Rudel, T. & Dandekar, T. Comprehensive flux modeling of chlamydia trachomatis proteome and qRT-PCR data indicate biphasic metabolic differences between elementary bodies and reticulate bodies during infection. Front. Microbiol. 10, 2350 (2019).","journal-title":"Front. Microbiol."},{"key":"73213_CR46","doi-asserted-by":"publisher","first-page":"8478","DOI":"10.1073\/pnas.1331135100","volume":"100","author":"RJ Belland","year":"2003","unstructured":"Belland, R. J. et al. Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis. Proc. Natl. Acad. Sci. USA 100, 8478\u20138483 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"73213_CR47","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1046\/j.1365-2958.2000.02057.x","volume":"37","author":"EI Shaw","year":"2000","unstructured":"Shaw, E. I. et al. Three temporal classes of gene expression during the Chlamydia trachomatis developmental cycle. Mol. Microbiol. 37, 913\u2013925 (2000).","journal-title":"Mol. Microbiol."},{"key":"73213_CR48","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1128\/JB.00933-15","volume":"198","author":"MM Weber","year":"2016","unstructured":"Weber, M. M. et al. A functional core of IncA is required for chlamydia trachomatis inclusion fusion. J. Bacteriol. 198, 1347\u20131355 (2016).","journal-title":"J. Bacteriol."},{"key":"73213_CR49","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1128\/IAI.70.7.3816-3823.2002","volume":"70","author":"KA Fields","year":"2002","unstructured":"Fields, K. A., Fischer, E. & Hackstadt, T. Inhibition of fusion of Chlamydia trachomatis inclusions at 32 degrees C correlates with restricted export of IncA. Infect. Immun. 70, 3816\u20133823 (2002).","journal-title":"Infect. Immun."},{"key":"73213_CR50","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.02545-24","volume":"16","author":"J Ehses","year":"2025","unstructured":"Ehses, J. et al. Development of an sRNA-mediated conditional knockdown system for Chlamydia trachomatis. mBio 16, e0254524 (2025).","journal-title":"mBio"},{"key":"73213_CR51","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1128\/IAI.68.1.360-367.2000","volume":"68","author":"RJ Suchland","year":"2000","unstructured":"Suchland, R. J., Rockey, D. D., Bannantine, J. P. & Stamm, W. E. Isolates of Chlamydia trachomatis that occupy nonfusogenic inclusions lack IncA, a protein localized to the inclusion membrane. Infect. Immun. 68, 360\u2013367 (2000).","journal-title":"Infect. Immun."},{"key":"73213_CR52","doi-asserted-by":"publisher","first-page":"e83989","DOI":"10.1371\/journal.pone.0083989","volume":"8","author":"CM Johnson","year":"2014","unstructured":"Johnson, C. M. & Fisher, D. J. Site-specific, insertional inactivation of inca in chlamydia trachomatis using a group II intron. PLoS ONE 8, e83989 (2014).","journal-title":"PLoS ONE"},{"key":"73213_CR53","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1128\/MMBR.00071-15","volume":"80","author":"RJ Bastidas","year":"2016","unstructured":"Bastidas, R. J. & Valdivia, R. H. Emancipating chlamydia: advances in the genetic manipulation of a recalcitrant intracellular pathogen. Microbiol. Mol. Biol. Rev. 80, 411\u2013427 (2016).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"73213_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1209879","volume":"14","author":"W Wan","year":"2023","unstructured":"Wan, W., Li, D., Li, D. & Jiao, J. Advances in genetic manipulation of Chlamydia trachomatis. Front. Immunol. 14, 1209879 (2023).","journal-title":"Front. Immunol."},{"key":"73213_CR55","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.chom.2018.04.002","volume":"23","author":"M Rother","year":"2018","unstructured":"Rother, M. et al. Combined human genome-wide RNAi and metabolite analyses identify IMPDH as a host-directed target against chlamydia infection. Cell Host Microbe 23, 661\u2013671.e668 (2018).","journal-title":"Cell Host Microbe"},{"key":"73213_CR56","doi-asserted-by":"publisher","unstructured":"LaBrie et al. Transposon mutagenesis in chlamydia trachomatis identifies CT339 as a ComEC homolog important for DNA uptake and lateral gene transfer. mBio 10, https:\/\/doi.org\/10.1128\/mbio.01343-01319 (2019).","DOI":"10.1128\/mbio.01343-01319"},{"key":"73213_CR57","doi-asserted-by":"publisher","first-page":"312","DOI":"10.12688\/wellcomeopenres.16068.1","volume":"6","author":"CE O\u2019Neill","year":"2021","unstructured":"O\u2019Neill, C. E. et al. An inducible transposon mutagenesis approach for the intracellular human pathogen Chlamydia trachomatis. Wellcome Open Res. 6, 312 (2021).","journal-title":"Wellcome Open Res."},{"key":"73213_CR58","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41392-022-00999-9","volume":"7","author":"M He","year":"2022","unstructured":"He, M. et al. PROTACs: great opportunities for academia and industry (an update from 2020 to 2021). Signal Transduct. Target Ther. 7, 181 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"73213_CR59","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/mmi.14849","volume":"117","author":"C Grohmann","year":"2022","unstructured":"Grohmann, C., Marapana, D. S. & Ebert, G. Targeted protein degradation at the host-pathogen interface. Mol. Microbiol. 117, 670\u2013681 (2022).","journal-title":"Mol. Microbiol."},{"key":"73213_CR60","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/ja.2016.138","volume":"70","author":"E Culp","year":"2017","unstructured":"Culp, E. & Wright, G. D. Bacterial proteases, untapped antimicrobial drug targets. J. Antibiot. 70, 366\u2013377 (2017).","journal-title":"J. Antibiot."},{"key":"73213_CR61","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1093\/nar\/gkad170","volume":"51","author":"W Rostain","year":"2023","unstructured":"Rostain, W. et al. Cas9 off-target binding to the promoter of bacterial genes leads to silencing and toxicity. Nucleic Acids Res. 51, 3485\u20133496 (2023).","journal-title":"Nucleic Acids Res."},{"key":"73213_CR62","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1089\/nat.2021.0085","volume":"32","author":"DR Corey","year":"2022","unstructured":"Corey, D. R., Damha, M. J. & Manoharan, M. Challenges and opportunities for nucleic acid therapeutics. Nucleic Acid Ther. 32, 8\u201313 (2022).","journal-title":"Nucleic Acid Ther."},{"key":"73213_CR63","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/mmi.14658","volume":"115","author":"B Milne-Davies","year":"2021","unstructured":"Milne-Davies, B., Wimmi, S. & Diepold, A. Adaptivity and dynamics in type III secretion systems. Mol. Microbiol. 115, 395\u2013411 (2021).","journal-title":"Mol. Microbiol."},{"key":"73213_CR64","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/s41564-018-0271-y","volume":"3","author":"JN Pruneda","year":"2018","unstructured":"Pruneda, J. N. et al. A Chlamydia effector combining deubiquitination and acetylation activities induces Golgi fragmentation. Nat. Microbiol. 3, 1377\u20131384 (2018).","journal-title":"Nat. Microbiol."},{"key":"73213_CR65","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fimmu.2020.00036","volume":"11","author":"JD Moreira","year":"2020","unstructured":"Moreira, J. D. et al. Functional inhibition of host histone deacetylases (HDACs) enhances in vitro and in vivo anti-mycobacterial activity in human macrophages and in zebrafish. Front. Immunol. 11, 36 (2020).","journal-title":"Front. Immunol."},{"key":"73213_CR66","doi-asserted-by":"crossref","unstructured":"Curcio A., Rocca R., Alcaro S., Artese A. The histone deacetylase family: structural features and application of combined computational methods. Pharmaceuticals 17, 620 (2024).","DOI":"10.3390\/ph17050620"},{"key":"73213_CR67","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s44316-024-00005-y","volume":"1","author":"M Chang","year":"2024","unstructured":"Chang, M., Ahn, S. J., Han, T. & Yang, D. Gene expression modulation tools for bacterial synthetic biology. Biotechnol. Sustain. Mater. 1, 6 (2024).","journal-title":"Biotechnol. Sustain. Mater."},{"key":"73213_CR68","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.biotechadv.2018.01.016","volume":"36","author":"F Bai","year":"2018","unstructured":"Bai, F., Li, Z., Umezawa, A., Terada, N. & Jin, S. Bacterial type III secretion system as a protein delivery tool for a broad range of biomedical applications. Biotechnol. Adv. 36, 482\u2013493 (2018).","journal-title":"Biotechnol. Adv."},{"key":"73213_CR69","doi-asserted-by":"publisher","first-page":"e0228941","DOI":"10.1371\/journal.pone.0228941","volume":"15","author":"S Wettstadt","year":"2020","unstructured":"Wettstadt, S. & Filloux, A. Manipulating the type VI secretion system spike to shuttle passenger proteins. PLoS One 15, e0228941 (2020).","journal-title":"PLoS One"},{"key":"73213_CR70","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm2343","volume":"8","author":"F Jiang","year":"2022","unstructured":"Jiang, F. et al. N-terminal signal peptides facilitate the engineering of PVC complex as a potent protein delivery system. Sci. Adv. 8, eabm2343 (2022).","journal-title":"Sci. Adv."},{"key":"73213_CR71","doi-asserted-by":"crossref","unstructured":"Van Lidth de Jeude J. F., Vermeulen J. L., Montenegro-Miranda P. S., Van den Brink G. R., Heijmans J. A protocol for lentiviral transduction and downstream analysis of intestinal organoids. J. Vis. Exp. 10, 52531 (2015).","DOI":"10.3791\/52531-v"},{"key":"73213_CR72","doi-asserted-by":"publisher","first-page":"e1002258","DOI":"10.1371\/journal.ppat.1002258","volume":"7","author":"Y Wang","year":"2011","unstructured":"Wang, Y. et al. Development of a transformation system for Chlamydia trachomatis: restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector. PLoS Pathog. 7, e1002258 (2011).","journal-title":"PLoS Pathog."},{"key":"73213_CR73","doi-asserted-by":"publisher","unstructured":"Zhang, H. Raw data output from ImageJ. https:\/\/doi.org\/10.6084\/m9.figshare.31986798.v1 (2026).","DOI":"10.6084\/m9.figshare.31986798.v1"},{"key":"73213_CR74","doi-asserted-by":"publisher","unstructured":"Zhang, H. Raw qPCR data exported from StepOne Plus System. https:\/\/doi.org\/10.6084\/m9.figshare.31988637.v1 (2026).","DOI":"10.6084\/m9.figshare.31988637.v1"},{"key":"73213_CR75","doi-asserted-by":"publisher","unstructured":"Zhang, H. Raw data exported from Leica X software for paper Minute-scale control of ubiquitin-mediated degradation reveals dynamics of bacterial secreted effector-functions. https:\/\/doi.org\/10.6084\/m9.figshare.31986777.v1 (2026).","DOI":"10.6084\/m9.figshare.31986777.v1"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73213-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73213-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73213-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T17:01:59Z","timestamp":1779123719000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73213-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["73213"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-73213-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4420"}}